Dr. Peter Kabos, MD
Claim this profileUniversity of Colorado Cancer Center
Studies Breast Cancer
Studies Brain Cancer
4 reported clinical trials
5 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
HER2 negative
2Brain Cancer
Stage IV
ER positive
PR positive
Affiliated Hospitals
Clinical Trials Peter Kabos, MD is currently running
Abemaciclib + Elacestrant
for Breast Cancer with Brain Metastasis
This is a multi-institutional, single arm, open label, Phase Ib/II study of abemaciclib in combination with elacestrant in patients with HR+/Her2- breast cancer metastatic to the brain. Patients may have received up to two prior lines of systemic chemotherapy for locally advanced or metastatic disease. There will be no limit on prior use of endocrine therapy including aromatase inhibitors, tamoxifen and fulvestrant, given a documented clinical benefit of elacestrant in this setting.
Recruiting1 award Phase 1 & 212 criteria
Elacestrant
for Breast Cancer
The purpose of this study is to evaluate the efficacy and safety of elacestrant over the course of 6 months in patients with estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting enzymes CDK4 and CDK6 inhibitor (CDK4/6i) in the metastatic setting.
Recruiting1 award Phase 217 criteria
More about Peter Kabos, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Peter Kabos, MD has experience with
- Elacestrant
- Palbociclib
- T-DM1
- Fulvestrant
- Abemaciclib
Breakdown of trials Peter Kabos, MD has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Kabos, MD specialize in?
Peter Kabos, MD focuses on Breast Cancer and Brain Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Peter Kabos, MD currently recruiting for clinical trials?
Yes, Peter Kabos, MD is currently recruiting for 3 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Peter Kabos, MD has studied deeply?
Yes, Peter Kabos, MD has studied treatments such as Elacestrant, Palbociclib, T-DM1.
What is the best way to schedule an appointment with Peter Kabos, MD?
Apply for one of the trials that Peter Kabos, MD is conducting.
What is the office address of Peter Kabos, MD?
The office of Peter Kabos, MD is located at: University of Colorado Cancer Center, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.